Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oral contraception in women with mild thrombophilia: what have we learned recently?

Thrombosis research - 1 Oct 2012

Blanco-Molina Ángeles

Abstract excerpt

Mild thrombophilias include heterozygous forms of Factor V Leiden and prothrombin G20210A mutation and high levels of factor VIII. These defects are responsible for only a moderate increase of venous thromboembolism (VTE) risk compared with strong thrombophilias (antithrombin III, protein C and protein S deficiencies and homozygous forms of factor V Leiden and G20210A prothrombin mutation). Combined oral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Patient Selection
Share to Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prothrombin

Share to Risk Assessment

Share to Severity of Illness Index

Share to Thrombophilia

Share to Venous Thromboembolism

Source

Identifiers

PMID: 23026651
DOI: 10.1016/j.thromres.2012.08.263

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oral contraception in women with mild thrombophilia: what have we learned recently?PMID 23026651Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

[Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].Semantic proximity Read ↗

[Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].Semantic proximity Read ↗

Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis.Semantic proximity Read ↗

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening.Semantic proximity Read ↗

Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.Semantic proximity Read ↗

Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review.Semantic proximity Read ↗

[From pill to pill: oral contraception, venous thrombosis and coagulation disorders].Semantic proximity Read ↗

Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.Semantic proximity Read ↗

Oral contraceptives and the risk of thrombosis and atherosclerosis.Semantic proximity Read ↗

The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.